img

Influenza Virus Vaccine (H1N1)


Published on: 2024-01-04 | No of Pages : 169 | Industry : Pharma & Healthcare

Publisher : MRA Reports | Format : PDF&Excel

Influenza Virus Vaccine (H1N1)

The global Influenza Virus Vaccine (H1N1) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on MRA Reports newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

CSL

Hualan Bio-Vaccine

Medimmune

NVS(Novartis)

Beijing Kexing Bio-Vaccine

Sanofi Pasteur

Beijing Tiantan Bio-Products

Baxter

GSK

Changchun Changsheng Bio-Technology

Jiangsu Yanshen Bio-Technology

Sinopharm

Zhejiang Tianyuan Bio-Pharmaceutical

Dalian Yalifeng Bio-Pharmaceutical



By Types

Intramuscular Vaccine

Nasal Spray Vaccine



By Applications

3 To 10 Years Old

10 To 18 Years Old

Above 18 Years Old

Other



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Influenza Virus Vaccine (H1N1) Revenue

1.5 Market Analysis by Type

1.5.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Intramuscular Vaccine

1.5.3 Nasal Spray Vaccine

1.6 Market by Application

1.6.1 Global Influenza Virus Vaccine (H1N1) Market Share by Application: 2022-2027

1.6.2 3 To 10 Years Old

1.6.3 10 To 18 Years Old

1.6.4 Above 18 Years Old

1.6.5 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Influenza Virus Vaccine (H1N1) Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Influenza Virus Vaccine (H1N1) Market Players Profiles

3.1 CSL

3.1.1 CSL Company Profile

3.1.2 CSL Influenza Virus Vaccine (H1N1) Product Specification

3.1.3 CSL Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Hualan Bio-Vaccine

3.2.1 Hualan Bio-Vaccine Company Profile

3.2.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification

3.2.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Medimmune

3.3.1 Medimmune Company Profile

3.3.2 Medimmune Influenza Virus Vaccine (H1N1) Product Specification

3.3.3 Medimmune Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 NVS(Novartis)

3.4.1 NVS(Novartis) Company Profile

3.4.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Specification

3.4.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Beijing Kexing Bio-Vaccine

3.5.1 Beijing Kexing Bio-Vaccine Company Profile

3.5.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification

3.5.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Sanofi Pasteur

3.6.1 Sanofi Pasteur Company Profile

3.6.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Specification

3.6.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Beijing Tiantan Bio-Products

3.7.1 Beijing Tiantan Bio-Products Company Profile

3.7.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Specification

3.7.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Baxter

3.8.1 Baxter Company Profile

3.8.2 Baxter Influenza Virus Vaccine (H1N1) Product Specification

3.8.3 Baxter Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 GSK

3.9.1 GSK Company Profile

3.9.2 GSK Influenza Virus Vaccine (H1N1) Product Specification

3.9.3 GSK Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Changchun Changsheng Bio-Technology

3.10.1 Changchun Changsheng Bio-Technology Company Profile

3.10.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification

3.10.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Jiangsu Yanshen Bio-Technology

3.11.1 Jiangsu Yanshen Bio-Technology Company Profile

3.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification

3.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Sinopharm

3.12.1 Sinopharm Company Profile

3.12.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Specification

3.12.3 Sinopharm Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Zhejiang Tianyuan Bio-Pharmaceutical

3.13.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Profile

3.13.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification

3.13.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Dalian Yalifeng Bio-Pharmaceutical

3.14.1 Dalian Yalifeng Bio-Pharmaceutical Company Profile

3.14.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification

3.14.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Influenza Virus Vaccine (H1N1) Market Competition by Market Players

4.1 Global Influenza Virus Vaccine (H1N1) Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Market Players (2016-2021)

4.3 Global Influenza Virus Vaccine (H1N1) Average Price by Market Players (2016-2021)

5 Global Influenza Virus Vaccine (H1N1) Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.1.2 Influenza Virus Vaccine (H1N1) Key Players in North America (2016-2021)

5.1.3 North America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.1.4 North America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.2.2 Influenza Virus Vaccine (H1N1) Key Players in East Asia (2016-2021)

5.2.3 East Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.2.4 East Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.3.2 Influenza Virus Vaccine (H1N1) Key Players in Europe (2016-2021)

5.3.3 Europe Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.3.4 Europe Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.4.2 Influenza Virus Vaccine (H1N1) Key Players in South Asia (2016-2021)

5.4.3 South Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.4.4 South Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.5.2 Influenza Virus Vaccine (H1N1) Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.5.4 Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.6.2 Influenza Virus Vaccine (H1N1) Key Players in Middle East (2016-2021)

5.6.3 Middle East Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.6.4 Middle East Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.7.2 Influenza Virus Vaccine (H1N1) Key Players in Africa (2016-2021)

5.7.3 Africa Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.7.4 Africa Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.8.2 Influenza Virus Vaccine (H1N1) Key Players in Oceania (2016-2021)

5.8.3 Oceania Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.8.4 Oceania Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.9.2 Influenza Virus Vaccine (H1N1) Key Players in South America (2016-2021)

5.9.3 South America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.9.4 South America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Influenza Virus Vaccine (H1N1) Market Size (2016-2021)

5.10.2 Influenza Virus Vaccine (H1N1) Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)

5.10.4 Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)

6 Global Influenza Virus Vaccine (H1N1) Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Influenza Virus Vaccine (H1N1) Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Influenza Virus Vaccine (H1N1) Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Influenza Virus Vaccine (H1N1) Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Influenza Virus Vaccine (H1N1) Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Influenza Virus Vaccine (H1N1) Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Influenza Virus Vaccine (H1N1) Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Influenza Virus Vaccine (H1N1) Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Influenza Virus Vaccine (H1N1) Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Influenza Virus Vaccine (H1N1) Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Influenza Virus Vaccine (H1N1) Consumption by Countries

7 Global Influenza Virus Vaccine (H1N1) Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Influenza Virus Vaccine (H1N1) (2022-2027)

7.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) (2022-2027)

7.3 Global Forecasted Price of Influenza Virus Vaccine (H1N1) (2022-2027)

7.4 Global Forecasted Production of Influenza Virus Vaccine (H1N1) by Region (2022-2027)

7.4.1 North America Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.3 Europe Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.7 Africa Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.9 South America Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Influenza Virus Vaccine (H1N1) Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Application (2022-2027)

8 Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.2 East Asia Market Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.3 Europe Market Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Countriy

8.4 South Asia Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.5 Southeast Asia Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.6 Middle East Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.7 Africa Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.8 Oceania Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.9 South America Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

8.10 Rest of the world Forecasted Consumption of Influenza Virus Vaccine (H1N1) by Country

9 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2027)

9.1 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Type (2016-2021)

9.2 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Type (2022-2027)

10 Global Influenza Virus Vaccine (H1N1) Consumption by Application (2016-2027)

10.1 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Application (2016-2021)

10.2 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Application (2022-2027)

11 Global Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis

11.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)

12 Global Influenza Virus Vaccine (H1N1) Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Influenza Virus Vaccine (H1N1) Distributors List

12.3 Influenza Virus Vaccine (H1N1) Customers

12.4 Influenza Virus Vaccine (H1N1) Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Influenza Virus Vaccine (H1N1) Revenue (US$ Million) 2016-2021

Table 6. Global Influenza Virus Vaccine (H1N1) Market Size by Type (US$ Million): 2022-2027

Table 7. Intramuscular Vaccine Features

Table 8. Nasal Spray Vaccine Features

Table 16. Global Influenza Virus Vaccine (H1N1) Market Size by Application (US$ Million): 2022-2027

Table 17. 3 To 10 Years Old Case Studies

Table 18. 10 To 18 Years Old Case Studies

Table 19. Above 18 Years Old Case Studies

Table 20. Other Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Influenza Virus Vaccine (H1N1) Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Influenza Virus Vaccine (H1N1) Market Growth Strategy

Table 46. Influenza Virus Vaccine (H1N1) SWOT Analysis

Table 47. CSL Influenza Virus Vaccine (H1N1) Product Specification

Table 48. CSL Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification

Table 50. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Medimmune Influenza Virus Vaccine (H1N1) Product Specification

Table 52. Medimmune Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Specification

Table 54. Table NVS(Novartis) Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Specification

Table 56. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Specification

Table 58. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Specification

Table 60. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Baxter Influenza Virus Vaccine (H1N1) Product Specification

Table 62. Baxter Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. GSK Influenza Virus Vaccine (H1N1) Product Specification

Table 64. GSK Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification

Table 66. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Specification

Table 68. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Sinopharm Influenza Virus Vaccine (H1N1) Product Specification

Table 70. Sinopharm Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification

Table 72. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Specification

Table 74. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Influenza Virus Vaccine (H1N1) Production Capacity by Market Players

Table 148. Global Influenza Virus Vaccine (H1N1) Production by Market Players (2016-2021)

Table 149. Global Influenza Virus Vaccine (H1N1) Production Market Share by Market Players (2016-2021)

Table 150. Global Influenza Virus Vaccine (H1N1) Revenue by Market Players (2016-2021)

Table 151. Global Influenza Virus Vaccine (H1N1) Revenue Share by Market Players (2016-2021)

Table 152. Global Market Influenza Virus Vaccine (H1N1) Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 155. North America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 157. North America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 159. East Asia Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 162. East Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 164. East Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 166. Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 169. Europe Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 171. Europe Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 173. South Asia Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 176. South Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 178. South Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 180. Southeast Asia Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 183. Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 185. Southeast Asia Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 187. Middle East Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 190. Middle East Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 192. Middle East Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 194. Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 197. Africa Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 199. Africa Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 201. Oceania Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 204. Oceania Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 206. Oceania Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 208. South America Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 211. South America Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 213. South America Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 215. Rest of the World Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Influenza Virus Vaccine (H1N1) Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Influenza Virus Vaccine (H1N1) Market Share (2016-2021)

Table 218. Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Influenza Virus Vaccine (H1N1) Market Share by Type (2016-2021)

Table 220. Rest of the World Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Influenza Virus Vaccine (H1N1) Market Share by Application (2016-2021)

Table 222. North America Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 223. East Asia Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 224. Europe Influenza Virus Vaccine (H1N1) Consumption by Region (2016-2021)

Table 225. South Asia Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 226. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 227. Middle East Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 228. Africa Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 229. Oceania Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 230. South America Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 231. Rest of the World Influenza Virus Vaccine (H1N1) Consumption by Countries (2016-2021)

Table 232. Global Influenza Virus Vaccine (H1N1) Production Forecast by Region (2022-2027)

Table 233. Global Influenza Virus Vaccine (H1N1) Sales Volume Forecast by Type (2022-2027)

Table 234. Global Influenza Virus Vaccine (H1N1) Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Influenza Virus Vaccine (H1N1) Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Influenza Virus Vaccine (H1N1) Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Influenza Virus Vaccine (H1N1) Sales Price Forecast by Type (2022-2027)

Table 238. Global Influenza Virus Vaccine (H1N1) Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Influenza Virus Vaccine (H1N1) Consumption Value Forecast by Application (2022-2027)

Table 240. North America Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 241. East Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 242. Europe Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 243. South Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 245. Middle East Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 246. Africa Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 247. Oceania Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 248. South America Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027 by Country

Table 250. Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)

Table 252. Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2022-2027)

Table 254. Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)

Table 256. Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2022-2027)

Table 258. Influenza Virus Vaccine (H1N1) Distributors List

Table 259. Influenza Virus Vaccine (H1N1) Customers List





Figure 1. Product Figure

Figure 2. Global Influenza Virus Vaccine (H1N1) Market Share by Type: 2021 VS 2027

Figure 3. Global Influenza Virus Vaccine (H1N1) Market Share by Application: 2021 VS 2027

Figure 4. North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 6. North America Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 7. United States Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 8. Canada Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 12. China Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 13. Japan Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 15. Europe Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 16. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Region in 2021

Figure 17. Germany Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 19. France Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 20. Italy Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 21. Russia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 22. Spain Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 25. Poland Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 27. South Asia Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 28. India Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 30. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 31. Indonesia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 37. Middle East Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 38. Turkey Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 40. Iran Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 42. Africa Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 43. Africa Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 44. Nigeria Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 47. Oceania Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 48. Australia Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 49. South America Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 50. South America Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 51. Brazil Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Influenza Virus Vaccine (H1N1) Consumption and Growth Rate

Figure 54. Rest of the World Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2021

Figure 55. Global Influenza Virus Vaccine (H1N1) Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Influenza Virus Vaccine (H1N1) Price and Trend Forecast (2022-2027)

Figure 58. North America Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 59. North America Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 75. South America Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Influenza Virus Vaccine (H1N1) Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Influenza Virus Vaccine (H1N1) Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 79. East Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 80. Europe Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 81. South Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 82. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 83. Middle East Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 84. Africa Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 85. Oceania Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 86. South America Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 87. Rest of the world Influenza Virus Vaccine (H1N1) Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1)

Figure 89. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Influenza Virus Vaccine (H1N1) Supply Chain Analysis